ODT - Odonate Therapeutics - Stock Forecast

Pharmaceuticals - Sector

Healthcare - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Odonate Therapeutics's activity chart (see below) currently has 5 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by PAUL CHOI from GOLDMAN on 22-Mar-2021. First documented stock forecast 06-Dec-2019.

Paul Choi Michael Yee

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 06-Dec-2019

$-12896 (-99.97%)

5 years 7 months 9 days ago
(22-Mar-2021)

0/2 (0%)

$-39596 (-99.99%)

Hold Since 22-Mar-2021

$45

$-12855 (-99.65%)

5 years 7 months 9 days ago
(22-Mar-2021)

0/1 (0%)

$-39555 (-99.89%)

Show more analysts

Which analyst most recently updated their price target on ODT (Odonate Therapeutics)?

Paul Choi

Which analyst has the most public recommendations on ODT (Odonate Therapeutics)?

Paul Choi works at GOLDMAN SACHS and has 3 price targets and 2 ratings on ODT

Which analyst is the currently most bullish on ODT (Odonate Therapeutics)?

Michael Yee with the highest potential upside of $-12855

Which analyst is the currently most reserved on ODT (Odonate Therapeutics)?

Paul Choi with the lowest potential downside of -$12896